Prompt-to-game builders
Platforms that turn prompts into playable games. 4 tools tracked. Picks: Best prompt-to-game AI builders · ship with no attribution.
| Tool | Free tier | Paid price (as shown) | Commercial licence | API / MCP | Checked |
|---|---|---|---|---|---|
| Rosebud AI Prompt-to-game builders | Newbie (free): 8,000 credits/week, hosted games, remixable | Indie Dev $15/mo; 10x Dev $30/mo; Pro $50/mo; Scale $100/mo | Free: Terms: 'The free version of the Services is for personal, non-commercial use only'; monetizing free-version UGC is prohibited Paid: Terms: paid users may use UGC commercially; pricing page lists 'Commercial rights' from 10x Dev ($30/mo); code download from Pro ($50/mo) | unverified | 2026-10-15 price: verified licence: verified |
| GDevelop Prompt-to-game builders | Free: open-source engine, 200 AI credits/week, Android/desktop publishing once per day | Silver $7.99/mo; Gold $13.99/mo; Pro $39.99/mo | Free: Open-source engine; free use allowed (Pro required for companies >$50k/yr revenue) Paid: Same | unverified | 2026-10-15 price: verified licence: partial |
| Summer Engine Prompt-to-game builders | Free app: editor, manual export, MCP connection to your engine | Pro $20/mo; Pro+ $60/mo; Ultra $200/mo | Free: AI Terms s.4.1: Summer assigns to you its rights (if any) in Generated Content; terms do not differ by plan Paid: Same; subject to the platform licence and third-party rights | MCP & CLI | 2026-10-15 price: verified licence: verified |
| Makko AI Prompt-to-game builders | Free: 150 art budget/month and 70 chat requests/week | Starter $20/mo (1,000 credits); $50/mo (3,000); $100/mo (6,000); $200/mo (13,000) | Free: FAQ: you retain full ownership, commercial releases allowed (not plan-limited in FAQ) Paid: Same; no revenue share or royalties | unverified | 2026-10-15 price: verified licence: verified |
Get the weekly what-changed email
Price changes, licence changes and new AI game-dev tools, pulled from tracked vendor pages every week. Free.
Form not loading? Subscribe on beehiiv.